Dr. Funda Meric-Bernstam, MD
Claim this profileM D Anderson Cancer Center
Expert in Solid Tumors
Expert in Cancer
30 reported clinical trials
90 drugs studied
About Funda Meric-Bernstam, MD
Education:
- Earned an MD from Yale University in 1991.
Experience:
- Serves as an Associate Professor of Surgical Oncology at The University of Texas MD Anderson Cancer Center.
- Specializes in translational research on breast cancer, with a focus on gene expression alterations and the mTOR signaling pathway.
- Utilizes a range of molecular biology techniques in her research.
- Took a two-year research hiatus at the NIH during her general surgery residency.
- Awarded the Society of University Surgeons (SUS) Resident Research Award for her contributions to surgical research.
Area of expertise
1Solid Tumors
Global LeaderStage IV
Stage III
KRAS positive
2Cancer
Global LeaderHER2 positive
Stage IV
Stage III
Affiliated Hospitals
Clinical Trials Funda Meric-Bernstam, MD is currently running
ACR-368
for Ovarian Cancer
This trial tests a new drug, ACR-368, alone or with a small dose of another drug, gemcitabine, in patients whose cancers don't respond to standard treatments. A special test helps decide which treatment might work best for each patient. Gemcitabine has been used with other drugs for various cancers, including pancreatic, lung, ovarian, and breast cancers.
Recruiting1 award Phase 1 & 210 criteria
Zotatifin
for Solid Tumors
This trial is testing a new drug called Zotatifin for patients with advanced cancers that haven't improved with standard treatments. The drug works by stopping cancer cells from making essential proteins, which may slow or stop the cancer.
Recruiting3 awards Phase 1 & 221 criteria
More about Funda Meric-Bernstam, MD
Clinical Trial Related8 years of experience running clinical trials · Led 30 trials as a Principal Investigator · 18 Active Clinical TrialsTreatments Funda Meric-Bernstam, MD has experience with
- Palbociclib
- Paclitaxel
- Binimetinib
- Pembrolizumab
- Ipatasertib
- Gemcitabine
Breakdown of trials Funda Meric-Bernstam, MD has run
Solid Tumors
Cancer
Tumors
Breast Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Funda Meric-Bernstam, MD specialize in?
Funda Meric-Bernstam, MD focuses on Solid Tumors and Cancer. In particular, much of their work with Solid Tumors has involved Stage IV patients, or patients who are Stage III.
Is Funda Meric-Bernstam, MD currently recruiting for clinical trials?
Yes, Funda Meric-Bernstam, MD is currently recruiting for 17 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that Funda Meric-Bernstam, MD has studied deeply?
Yes, Funda Meric-Bernstam, MD has studied treatments such as Palbociclib, Paclitaxel, Binimetinib.
What is the best way to schedule an appointment with Funda Meric-Bernstam, MD?
Apply for one of the trials that Funda Meric-Bernstam, MD is conducting.
What is the office address of Funda Meric-Bernstam, MD?
The office of Funda Meric-Bernstam, MD is located at: M D Anderson Cancer Center, Houston, Texas 77030 United States. This is the address for their practice at the M D Anderson Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.